Skip to main content
Log in

Preliminary results on labelling antibody Mab B72.3 with90Y

  • Letter to the Editor
  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

90Y is coupled through DTPA chelator in Mab B72.3 antibody with good radiochemical yield. The process of labelling is relatively fast (30 min). Care must be taken on parameters of quality control, because they influence the results. The difference was 1.5 time between the analysis performed at the 1st and the 12th minutes after mixing labelled antibody with DTPA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. D. J. Hnatovich et al., J. Nucl. Med., 26 (1985) 503.

    PubMed  Google Scholar 

  2. Y. A. Roger et al., Radionuclides for therapy: A Review, Proc. 4th Bottstein Colloquium on the Use of Radionuclies and Vehicles for Tumour Therapy, 13–14 June 1986.

  3. Oncoscint: An advance in the detection and management of colorectal carcinoma, Eurocetus ed., 1991.

  4. S. Malja, K. Schomäcker. Some aspects of the90Sr-90Y generator production. BPU-2 Congress, Izmir, 1994.

  5. A. M. Zimmer et al., Nucl. Med. Biol., 15 (1986) 717.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malja, S., Schomäcker, K. & Damani, G. Preliminary results on labelling antibody Mab B72.3 with90Y. J Radioanal Nucl Chem 218, 255–257 (1997). https://doi.org/10.1007/BF02039346

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02039346

Keywords

Navigation